Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis
2022 · Arthritis Research & Therapy · 16 citations
https://doi.org/10.1186/s13075-022-02836-4
O
Oh Chan Kwon
Ulsan College(KR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
901
Citations
18
h-index
37
i10-index
Oh Chan Kwon is an academic researcher from Ulsan College. The author has contributed to research in topics: Systemic Lupus Erythematosus Research & Spondyloarthritis Studies and Treatments & Rheumatoid Arthritis Research and Therapies. The author has an h-index of 18, co-authored 99 publications.
ORCID: 0000-0001-7962-3697Papers by this author
worksNon-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
2020 · Arthritis Research & Therapy · 11 citations
https://doi.org/10.1186/s13075-020-02223-x
Comparative risk of incident and recurrent acute anterior uveitis across different biological agents in patients with ankylosing spondylitis
2024 · Lara D. Veeken · 11 citations
https://doi.org/10.1093/rheumatology/keae003
Cardiovascular risk according to biological agent exposure in patients with ankylosing spondylitis: a nationwide population-based study
2024 · Clinical Rheumatology · 6 citations
https://doi.org/10.1007/s10067-024-07225-7
Higher gamma-glutamyl transferase levels are associated with an increased risk of incident systemic sclerosis: a nationwide population-based study
2023 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-023-49183-1
Drug survival and change of disease activity using a second janus kinase inhibitor in patients with difficult-to-treat rheumatoid arthritis who failed to a janus kinase inhibitor and subsequent biologics
2024 · Advances in Rheumatology · 2 citations
https://doi.org/10.1186/s42358-024-00368-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat